This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 3 EPO patents. Top assignee: Onyx Therapeutics, Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Mark Nguyen Ho: Innovator in Enzyme Inhibition
Introduction
Mark Nguyen Ho is a notable inventor based in San Jose, California. He has made significant contributions to the field of enzyme inhibition, particularly through his innovative patent. His work focuses on enhancing the solubility of proteasome inhibitors, which has important implications for medical treatments.
Latest Patents
Mark Nguyen Ho holds a patent for a composition aimed at enzyme inhibition. The patent describes compositions comprising one or more practically insoluble proteasome inhibitors and a cyclodextrin, particularly a substituted cyclodextrin. These compositions substantially increase the solubility of proteasome inhibitors and facilitate their administration. Additionally, the compositions may optionally include a buffer, and methods of treatment using these compositions are also disclosed. He has 1 patent to his name.
Career Highlights
Throughout his career, Mark has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Onyx Therapeutics, Inc. and Proteolix, Inc. His experience in these organizations has contributed to his expertise in enzyme inhibition and related fields.
Collaborations
Mark has collaborated with several professionals in his field, including Evan Lewis and Fabiana N Fonseca. These collaborations have likely enriched his research and development efforts.
Conclusion
Mark Nguyen Ho is a distinguished inventor whose work in enzyme inhibition has the potential to advance medical treatments significantly. His innovative compositions and collaborations reflect his commitment to improving healthcare solutions.